Hongwei Cheng

机构：Ontario Institute for Cancer Research, BC Cancer Agency, Anhui Medical University, First Affiliated Hospital of Anhui Medical University · ORCID：0009-0007-9582-8415

发表论文 26 篇 · 总被引 79 次 · h-index 6

代表论文

• Radiotherapy Resistance of 3D Bioprinted Glioma via ITGA2/p‐AKT Signaling Pathway (2024 · Advanced Healthcare Materials · 被引 15)
• The role of brain–liver–gut Axis in neurological disorders (2025 · Burns & Trauma · 被引 12)
• Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes (2023 · Journal of Neuro-Oncology · 被引 12)
• Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration (2023 · Heliyon · 被引 7)
• Interfering with CALCRL expression inhibits glioma proliferation, promotes apoptosis, and predicts prognosis in low-grade gliomas (2022 · Annals of Translational Medicine · 被引 6)
• Machine learning-based scoring model for predicting mortality in ICU-admitted ischemic stroke patients with moderate to severe consciousness disorders (2025 · Frontiers in Neurology · 被引 4)